²é¿´: 2990  |  »Ø¸´: 9
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

hfsr

Òø³æ (³õÈëÎÄ̳)

[ÇóÖú] Ë­°ïæ²é¸öÑÎËáÃÀ½ð¸ÕµÄ±ê×¼£¬Ð»Ð»ÁË¡£

Ë­°ïæ²é¸öÑÎËáÃÀ½ð¸ÕµÄ±ê×¼£¬Ð»Ð»ÁË¡£
Ò»¶¨ÒªUSP36µÄ£¬
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

06ҩѧ

ľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
hfsr(zhychen2008´ú·¢): ½ð±Ò+10, ¶àл»ØÌû½»Á÷ 2013-10-20 23:08:46
Memantine Hydrochloride Tablets
DEFINITION

Memantine Hydrochloride Tablets contain an amount of memantine hydrochloride equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of memantine hydrochloride (C12H21N ¡¤HCl).
IDENTIFICATION
•  A. Infrared Absorption  197K
Analytical range:   4000 to 400 cm ¨C1
Standard:   6.7 mg/mL of USP Memantine Hydrochloride RS in dichloromethane. Shake for 10 min, and pass through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide.
Sample:   6.7 mg/mL of Memantine Hydrochloride in dichloromethane from NLT 20 crushed Tablets. Shake for 10 min, and centrifuge for 10 min. Pass the supernatant through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide.
Acceptance criteria:   Fingerprint region of the Standard and Sample spectrum exhibit maxima at the same wave numbers.
•  B. The retention time of the memantine peak in the Sample solution corresponds to that of the memantine peak in the Standard solution, as obtained in the Assay.
ASSAY
•  Procedure
Solution A:   200 mg/mL of sodium hydroxide in water
Internal standard solution:   25 µg/mL of USP Amantadine Hydrochloride RS in water
Standard stock solution:   25 µg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add methanol to fill 40% of the final flask volume, and sonicate. Dilute with water to volume.
Standard solution:   Pipet 4.0 mL each of Internal standard solution and Standard stock solution into a test tube. Add 2 mL of Solution A, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 3 min. Allow the two layers to separate. Inject the toluene layer.
Sample stock solution:   Nominally 20 µg/mL of memantine hydrochloride prepared as follows. Transfer a suitable number of Tablets to a volumetric flask to obtain a 0.1 mg/mL memantine hydrochloride solution. Add methanol to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Add water to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Dilute with water to volume, and centrifuge a portion for 10 min. Pipet a suitable volume of the clear centrifugate into a volumetric flask, and dilute with water to volume.
Sample solution:   Pipet 5.0 mL of the Sample stock solution, 4.0 mL of Internal standard solution, and 2 mL of Solution A into a test tube, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 5 min. Allow the two layers to separate. Inject the toluene layer.
Blank:   To 5.0 mL of 80 µL/mL of methanol in water add 2 mL Solution A, and mix on a vortex mixer for 1 min. Add 4.0 mL of tolune, and cyclomix on vortex for 5 min. Allow the two layers to separate. Inject the toluene layer.
Chromatographic system  
(See Chromatography  621 , System Suitability.)
Mode:   GC
Detector:   Flame ionization
Column:   30-m ¡Á 0.32-mm; 0.25-µm packing G27
Temperatures
Injection port:   210
Detector:   300
Oven:   See Table 1.
Table 1
Initial
Temperature
()        Temperature
Ramp
(/min)        Final
Temperature
()        Hold Time at Final
Temperature
(min)
50        0        50        2
50        20        140        0
140        30        200        5
Carrier gas:   Helium
Flow rate:   34.8 psi
Injection volume:   4 µL
Injection type:   Split ratio, 1:10
System suitability
Sample:   Standard solution
[ NOTE¡ª The relative retention times for amantadine and memantine are 0.97 and 1.0, respectively. ]
Suitability requirements
Resolution:   NLT 2.0 between amantadine and memantine
Tailing factor:   NMT 2.5 for amantadine and NMT 2.0 for memantine
Relative standard deviation:   NMT 2.0% for the ratio of the peak areas of amantadine and memantine
Analysis
Samples:   Standard solution, Sample solution, and Blank

Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ¡¤HCl) in the portion of Tablets taken:
Result = ( R U / R S ) ¡Á ( C S / C U ) ¡Á 100
R U        = peak area ratio of memantine to amantadine from the Sample solution
R S        = peak area ratio of memantine to amantadine from the Standard solution
C S        = concentration of USP Memantine Hydrochloride RS in the Standard solution (µg/mL)
C U        = nominal concentration of memantine hydrochloride in the Sample solution (µg/mL)
Acceptance criteria:   90.0%¨C110.0%
PERFORMANCE TESTS
•   Dissolution  711
Medium:   0.1 N hydrochloric acid with sodium chloride (2g/L of sodium chloride in water), adjusted with hydrochloric acid to a pH of 1.2; 900 mL
Apparatus 1:   100 rpm
Time:   30 min
Standard stock solution:   (L/900) mg/mL of USP Memantine Hydrochloride RS in Medium, where L is the label claim in mg/Tablet
Internal standard solution:   28 µg/mL of USP Amantadine Hydrochloride RS in Medium
Standard solution
For Tablets labeled to contain 5 mg:   Transfer 5 mL of the Standard stock solution to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
For Tablets labeled to contain 10mg:   Transfer 5 mL of the Standard stock solution to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
Sample solution:   Pass a portion of the solution under test through a suitable filter.
For Tablets labeled to contain 5 mg:   Transfer 5 mL of the filtrate to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
For Tablets labeled to contain 10 mg:   Transfer 5 mL of the filtrate to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer.
Chromatographic system  
(See Chromatography  621 , System Suitability.)
Mode:   GC, splitless
Detector:   Flame ionization
Column:   30-m ¡Á 0.32-mm; 0.25-µm packing G27
Flow rate:   34.8 psi
Temperatures
Injection port:   210
Detector:   300
Oven:   See Table 2.
Table 2
Initial
Temperature
()        Temperature
Ramp
(/min)        Final
Temperature
()        Hold Time at Final
Temperature
(min)
50        0        50        2
50        20        140        0
140        30        200        5
Carrier gas:   Helium
Injection volume:   4 µL
System suitability
Sample:   Standard solution
Suitability requirements
Resolution:   NLT 2.0 between amantadine and memantine
Tailing factor:   NMT 2.0 each for amantadine and memantine
Relative standard deviation:   NMT 2.0% for both the amantadine and memantine peaks
Analysis
Samples:   Standard solution and Sample solution

Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ¡¤HCl) dissolved:
Result = ( R u / R s ) ¡Á ( C s /L) ¡Á V ¡Á 100
R U        = peak area ratio of memantine to amantadine from the Sample solution
R S        = peak area ratio of memantine to amantadine from the Standard solution
C S        = concentration of USP Memantine Hydrochloride RS from the Standard solution (µg/mL)
V        = volume of Medium, 900 mL
L        = label claim (mg/Tablet)
Tolerances:   NLT 80% (Q) of the labeled amount of memantine hydrochloride (C12H21N ¡¤HCl) is dissolved.
•   Uniformity of Dosage Units  905 : Meet the requirements
IMPURITIES
•  Limit of Memantine¨CLactose Adduct
[ NOTE¡ª Perform this test if lactose is present in the formulation. ]
Solution A:   40 mg/mL of sodium hydroxide in water
Buffer:   Dissolve 3.3 g of monobasic potassium phosphate and 2.3 g of sodium 1-octane sulfonate in 1 L of water. Adjust with Solution A to a pH of 6.1.
Mobile phase:   Acetonitrile, methanol, and Buffer (26:4:70)
Standard solution:   0.2 mg/mL of USP Memantine Hydrochloride RS in Mobile phase
Sample solution:   Nominally 10 mg/mL of memantine hydrochloride from NLT 25 crushed Tablets, prepared as follows. Transfer an amount of powder equivalent to 100 mg of memantine hydrochloride to a 20-mL volumetric flask. Add 10 mL of Mobile phase, and sonicate for 30 min. Centrifuge, and pass a portion of the centrifugate through a suitable filter of 0.45-µm pore size.
Chromatographic system  
(See Chromatography  621 , System Suitability.)
Mode:   LC
Detector:   Refractive index
Column:   4.6-mm ¡Á 15-cm; 5-µm packing L1
Temperatures
Column:   40
Detector:   35
Flow rate:   1.3 mL/min
Injection volume:   50 µL
Run time:   1.3 times the retention time of the memantine peak
System suitability
Sample:   Standard solution
Suitability requirements
Tailing factor:   NMT 3.5
Relative standard deviation:   NMT 10.0%
Analysis
Samples:   Standard solution and Sample solution

Calculate the percentage of the memantine¨Clactose adduct in the portion of Tablets taken:
Result = ( r U / r S ) ¡Á ( C S / C U ) ¡Á (1/F) ¡Á 100
r U        = peak response of the memantine¨Clactose adduct from the Sample solution
r S        = peak response of memantine from the Standard solution
C S        = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL)
C U        = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL)
F        = relative response factor of the memantine¨Clactose adduct (see Table 3)
Acceptance criteria:   See Table 3.
Disregard all peaks other than the memantine¨Clactose adduct peak.
Table 3
Name        Relative
Retention
Time        Relative
Response
Factor        Acceptance
Criteria,
NMT (%)
Memantine¨Clactose adduct        0.41        0.53        0.5
Memantine        1.0        1.0         ¡ª
•  Organic Impurities
Solution A:   1 N sodium hydroxide
Standard stock solution A:   0.5 mg/mL each of USP Memantine Related Compound A RS, USP Memantine Related Compound B RS, USP Memantine Related Compound C RS, USP Memantine Related Compound D RS, and USP Memantine Related Compound E RS in n-hexane
Standard stock solution B:   12.5 mg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 15% of the final flask volume and n-hexane to fill 10% of the final flask volume. Mix for 10 min.
System suitability solution:   Pipet 4.0 mL of the n-hexane layer from Standard stock solution B into a 10-mL volumetric flask. Add 0.5 mL of Standard stock solution A, and dilute with n-hexane to volume.
Standard stock solution:   1.3 mg/mL of USP Memantine Hydrochloride RS in n-hexane prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 30% of the final flask volume, and mix for 5 min. Add n-hexane to fill 40% of the final flask volume, and shake for 10 min. Transfer the contents of the flask into a separator. Allow the layers to separate, and filter a portion of the top n-hexane layer through anhydrous sodium sulfate. Use the clear solution.
Standard solution:   Pipet 2.0 mL of the clear solution from the Standard stock solution into a 100-mL volumetric flask, and dilute with n-hexane to volume.
Sample solution:   Nominally 5 mg/mL of memantine hydrochloride in n-hexane from NLT 20 crushed Tablets, prepared as follows. Transfer a weighed amount of powder equivalent to 100 mg of memantine hydrochloride to a suitable volumetric flask. Add Solution A to fill 15% of the final flask volume. Shake to disperse the material, and shake for 5 min. Sonicate for 5 min with intermittent shaking. Add n-hexane to fill 20% of the final flask volume, and shake for 10 min. Transfer the contents into a separator. Allow the layers to separate, and filter a portion of the top hexane layer through anhydrous sodium sulfate. Use the clear solution.
Chromatographic system  
(See Chromatography  621 , System Suitability.)
Mode:   GC
Detector:   Flame ionization
Column:   50-m ¡Á 0.32-mm; 0.52-µm packing G27
Temperatures
Injection port:   220
Detector:   300
Oven:   See Table 4.
Table 4
Initial
Temperature
()        Temperature
Ramp
(/min)        Final
Temperature
()        Hold Time at Final
Temperature
(min)
50        0        50        2
50        5        145        0
145        10        250        20
Carrier gas:   Helium
Flow rate:   4.0 ¡À 0.2 mL/min
Injection volume:   3 µL
Injection type:   Split ratio, 1:20
System suitability
Samples:   System suitability solution and Standard solution
[ NOTE¡ª See Table 5 for the relative retention times. ]
Suitability requirements
Resolution:   NLT 2.0 between memantine and memantine related compound B, NLT 2.0 between memantine related compound B and memantine related compound C, System suitability solution
Tailing factor:   NMT 2.0, Standard solution
Relative standard deviation:   NMT 10.0%, Standard solution
Analysis
Samples:   Standard solution and Sample solution

Calculate the percentage of USP Memantine Related Compound E RS or any individual degradation product in the portion of Tablets taken:
Result = ( r U / r S ) ¡Á ( C S / C U ) ¡Á 100
r U        = peak response of USP Memantine Related Compound E RS or any individual degradation product from the Sample solution
r S        = peak response of memantine hydrochloride from the Standard solution
C S        = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL)
C U        = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL)
Acceptance criteria:   See Table 5.
Table 5
Name        Relative
Retention
Time        Acceptance
Criteria,
NMT (%)
Memantine related compound Aa        0.77         ¡ª
Memantine        1.0         ¡ª
Memantine related compound Ba        1.03         ¡ª
Memantine related compound Ca        1.1         ¡ª
Memantine related compound Da        1.2         ¡ª
Memantine related compound E        1.4        0.15
Any individual unspecified degradation product         ¡ª        0.20
Total impuritiesb         ¡ª        0.5
a   Process impurities controlled in the drug substance and are included for identification only. Not reported for the drug product and not included in the total impurities
b   Excludes memantine¨Clactose adduct monitored in the test for Limit of Memantine¨CLactose Adduct.
ADDITIONAL REQUIREMENTS
•  Packaging and Storage: Preserve in tight containers. Store at controlled room temperature.
•   USP Reference Standards  11
USP Amantadine Hydrochloride RS
USP Memantine Hydrochloride RS
USP Memantine Related Compound A RS
1,3-Dimethyladamantane.     
C12H20       164.29
USP Memantine Related Compound B RS  
3,5-Dimethyladamantane-1-ol.     
C12H20O       180.29
USP Memantine Related Compound C RS  
1-Chloro-3,5-dimethyladamantane.     
C12H19Cl       198.73
USP Memantine Related Compound D RS  
1-Bromo-3,5-dimethyladamantane.     
C12H19Br       243.18
USP Memantine Related Compound E RS  
N-3,5-Dimethyladamantan-1-yl formamide.     
C13H21NO       207.31

» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

ѧҩΪÃñ
5Â¥2013-10-20 23:02:07
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 10 ¸ö»Ø´ð

e_liang369

½ð³æ (ÕýʽдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ö±½Óµ½drugfutureÉÏÈ¥²é
http://www.drugfuture.com/standard/
±¯´ßµÄÑз¢£¡
2Â¥2013-10-18 12:28:32
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

hfsr

Òø³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by e_liang369 at 2013-10-18 12:28:32
Ö±½Óµ½drugfutureÉÏÈ¥²é
http://www.drugfuture.com/standard/

ÄÇÉÏÃæÃ»ÓÐUSP36°æ°¡
3Â¥2013-10-19 20:33:53
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

qiuqinglei5020

½ð³æ (СÓÐÃûÆø)

ÁòËá´óʦ


Õâ¸öÒ»¶¨Ã»ÓÐUSP36£¬ÄãÒ²±ðÕÒÁË£¡
4Â¥2013-10-20 12:24:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 289Çóµ÷¼Á +5 ˶ÐǸ° 2026-03-23 5/250 2026-03-24 17:09 by helloÆßÆß
[¿¼ÑÐ] 307Çóµ÷¼Á +5 ³¬¼¶ÒÁ°º´óÍõ 2026-03-24 5/250 2026-03-24 15:46 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 085404µç×ÓÐÅÏ¢284·ÖÇóµ÷¼Á +4 13659058978 2026-03-24 4/200 2026-03-24 12:15 by syl20081243
[¿¼ÑÐ] 07»¯Ñ§280·ÖÇóµ÷¼Á +4 722865 2026-03-23 4/200 2026-03-24 00:01 by chixmc
[¿¼ÑÐ] 0854 ¿¼Ñе÷¼Á ÕÐÉúÁË£¡AI ·½Ïò +4 pk3725069 2026-03-19 16/800 2026-03-23 23:09 by Íô£¡£¿£¡
[¿¼ÑÐ] 284Çóµ÷¼Á +3 yanzhixue111 2026-03-23 6/300 2026-03-23 22:58 by pswait
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖØÇì´óѧ085700×ÊÔ´Óë»·¾³£¬×Ü·Ö308Çóµ÷¼Á +7 īīĮ 2026-03-23 8/400 2026-03-23 20:36 by Creta
[¿¼ÑÐ] ¿¼Ñл¯Ñ§308·ÖÇóµ÷¼Á +7 ÄãºÃÃ÷ÌìÄãºÃ 2026-03-23 8/400 2026-03-23 18:39 by macy2011
[¿¼ÑÐ] Ò»Ö¾Ô¸ÖйúʯÓÍ´óѧ£¨»ª¶«£© ±¾¿ÆÆë³¹¤Òµ´óѧ +4 ʯÄÜΰ 2026-03-17 4/200 2026-03-23 17:51 by 17862566385
[¿¼ÑÐ] 291 Çóµ÷¼Á +4 »¯¹¤2026½ì±ÏÒµÉ 2026-03-21 5/250 2026-03-23 16:46 by »¯¹¤2026½ì±ÏÒµÉ
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄϾ©Àí¹¤´óѧ085701×ÊÔ´Óë»·¾³302·ÖÇóµ÷¼Á +5 ¿ûè÷ÎÀ¶Ó 2026-03-18 7/350 2026-03-23 16:26 by lingjue
[¿¼ÑÐ] 350Çóµ÷¼Á +6 weudhdk 2026-03-19 6/300 2026-03-23 15:47 by tangyuan0840221
[¿¼ÑÐ] 287Çóµ÷¼Á +8 ³¿»èÏßÓëÐǺ£ 2026-03-19 9/450 2026-03-22 17:01 by i_cooler
[¿¼ÑÐ] Ò»Ö¾Ô¸ Î÷±±´óѧ £¬070300»¯Ñ§Ñ§Ë¶£¬×Ü·Ö287£¬Ë«·ÇÒ»±¾£¬Çóµ÷¼Á¡£ +3 ³¿»èÏßÓëÐǺ£ 2026-03-20 3/150 2026-03-22 16:00 by ColorlessPI
[¿¼ÑÐ] Çóµ÷¼Á +5 Zhangbod 2026-03-21 7/350 2026-03-22 13:13 by Zhangbod
[¿¼ÑÐ] 286·ÖÈ˹¤ÖÇÄÜרҵÇëÇóµ÷¼ÁÔ¸Òâ¿ç¿¼£¡ +4 lemonzzn 2026-03-17 8/400 2026-03-21 22:49 by lemonzzn
[¿¼ÑÐ] 280Çóµ÷¼Á +11 ¹¾ààÏþÏþ 2026-03-18 12/600 2026-03-21 22:40 by ACS Nano¡ª¡ª
[¿¼ÑÐ] »¯Ñ§Çóµ÷¼Á +4 ÁÙÔó¾³llllll 2026-03-17 5/250 2026-03-21 02:23 by JourneyLucky
[¿¼ÑÐ] 295Çóµ÷¼Á +4 Ò»Ö¾Ô¸¾©Çø211 2026-03-18 6/300 2026-03-20 23:41 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏѧ˶318Çóµ÷¼Á +5 February_Feb 2026-03-19 5/250 2026-03-19 23:51 by 23Postgrad
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û